Lowest-Rated StocksLowest-RatedNYSE:AGL agilon health (AGL) Stock Price, News & Analysis → Shocking: One AI startup's revenue could surge 4,735% (From Manward Press) (Ad) Free AGL Stock Alerts $4.98 +0.15 (+3.11%) (As of 05/7/2024 ET) Add Compare Share Share Today's Range$4.75▼$5.0150-Day Range$4.46▼$6.3652-Week Range$4.41▼$26.75Volume4.52 million shsAverage Volume5.58 million shsMarket Capitalization$2.05 billionP/E RatioN/ADividend YieldN/APrice Target$9.32 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get agilon health alerts: Email Address agilon health MarketRank™ Stock AnalysisAnalyst RatingHold2.18 Rating ScoreUpside/Downside87.2% Upside$9.32 Price TargetShort InterestBearish15.25% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment-0.12Based on 19 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.33) to ($0.17) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.57 out of 5 starsMedical Sector662nd out of 903 stocksMiscellaneous Health & Allied Services, Not Elsewhere Classified Industry7th out of 7 stocks 4.1 Analyst's Opinion Consensus Ratingagilon health has received a consensus rating of Hold. The company's average rating score is 2.18, and is based on 4 buy ratings, 12 hold ratings, and 1 sell rating.Amount of Analyst Coverageagilon health has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about agilon health's stock forecast and price target. Previous Next 2.0 Short Interest Percentage of Shares Shorted15.25% of the float of agilon health has been sold short.Short Interest Ratio / Days to Coveragilon health has a short interest ratio ("days to cover") of 8.9.Change versus previous monthShort interest in agilon health has recently decreased by 2.13%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend Yieldagilon health does not currently pay a dividend.Dividend Growthagilon health does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for AGL. Previous Next 1.0 News and Social Media Coverage News Sentimentagilon health has a news sentiment score of -0.12. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.38 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 19 news articles for agilon health this week, compared to 5 articles on an average week.Search InterestOnly 3 people have searched for AGL on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.MarketBeat FollowsOnly 2 people have added agilon health to their MarketBeat watchlist in the last 30 days. This is a decrease of -33% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, agilon health insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 3.20% of the stock of agilon health is held by insiders.Read more about agilon health's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for agilon health are expected to grow in the coming year, from ($0.33) to ($0.17) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of agilon health is -7.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of agilon health is -7.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share Ratioagilon health has a P/B Ratio of 3.06. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Priority GoldBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentially cancel your money. You see Biden and the Fed have teamed up to create a controllable, traceable, programmable digital currency to replace the dollar...Get your free information kit NOW, before it's too late. About agilon health Stock (NYSE:AGL)agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.Read More AGL Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AGL Stock News HeadlinesMay 8, 2024 | prnewswire.comagilon health, inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before May 20, 2024 to Discuss Your Rights - AGLMay 8, 2024 | finance.yahoo.comAgilon Health Inc (AGL) Q1 2024 Earnings Call Transcript Highlights: Robust Growth Amidst ...May 8, 2024 | Smallcaps Daily (Ad)The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySee how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space.May 7, 2024 | finance.yahoo.comAgilon Health Inc (AGL) Q1 2024 Earnings: Aligns with EPS Projections Despite Revenue SurgeMay 7, 2024 | businesswire.comagilon health Reports First Quarter 2024 ResultsMay 7, 2024 | businesswire.comagilon health Announces New Physician Partnerships for 2025May 7, 2024 | prnewswire.comSHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in agilon health, inc. with Losses of $100,000 to Contact the FirmMay 7, 2024 | prnewswire.comagilon health, inc. Class Action: The Gross Law Firm Reminds agilon health Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2024 - AGLMay 8, 2024 | Smallcaps Daily (Ad)The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySee how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space.May 6, 2024 | prnewswire.comShareholders that lost money on agilon health, inc.(AGL) should contact Levi & Korsinsky about pending Class Action - AGLMay 5, 2024 | americanbankingnews.comagilon health (AGL) to Release Quarterly Earnings on TuesdayMay 3, 2024 | prnewswire.comAGILON HEALTH SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against agilon health, inc. - AGLMay 3, 2024 | prnewswire.comAGL LAWSUIT ALERT: The Gross Law Firm Notifies agilon health, inc. Investors of a Class Action Lawsuit and Upcoming DeadlineMay 3, 2024 | prnewswire.comSHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of agilon healthMay 3, 2024 | markets.businessinsider.comStifel Nicolaus Reaffirms Their Hold Rating on Agilon Health (AGL)May 3, 2024 | americanbankingnews.comagilon health (NYSE:AGL) PT Lowered to $7.00May 2, 2024 | americanbankingnews.comagilon health (NYSE:AGL) Stock Price Down 7.1% After Analyst DowngradeMay 1, 2024 | markets.businessinsider.comClass Action Reminder: Kessler Topaz Meltzer & Check, LLP Reminds agilon health, inc. Investors of Securities Fraud Class Action Lawsuit (AGL)May 1, 2024 | prnewswire.comSHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in agilon health, inc. with Losses of $100,000 to Contact the FirmApril 28, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against agilon health, inc. - AGLApril 27, 2024 | businesswire.comagilon health, inc. Investors: May 20, 2024 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLPApril 27, 2024 | investing.comagilon health Inc (AGL)April 26, 2024 | prnewswire.comAGILON HEALTH SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against agilon health, inc. - AGLApril 26, 2024 | prnewswire.comThe Gross Law Firm Notifies agilon health, inc. Investors of a Class Action Lawsuit and Upcoming Deadline - AGLApril 26, 2024 | prnewswire.comThe Gross Law Firm Notifies agilon health, inc. Investors of a Class Action Lawsuit and Upcoming Deadline - AGLApril 26, 2024 | prnewswire.comThe Gross Law Firm Notifies agilon health, inc. Investors of a Class Action Lawsuit and Upcoming Deadline - AGLApril 25, 2024 | prnewswire.comSHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of agilon healthSee More Headlines Receive AGL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for agilon health and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/27/2024Today5/07/2024Next Earnings (Confirmed)5/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Miscellaneous health & allied services, not elsewhere classified Sub-IndustryN/A Current SymbolNYSE:AGL CUSIPN/A CIK1831097 Webagilonhealth.com Phone562-256-3800FaxN/AEmployees1,117Year FoundedN/APrice Target and Rating Average Stock Price Target$9.32 High Stock Price Target$18.00 Low Stock Price Target$5.00 Potential Upside/Downside+87.2%Consensus RatingHold Rating Score (0-4)2.18 Research Coverage17 Analysts Profitability EPS (Most Recent Fiscal Year)($0.65) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-262,600,000.00 Net Margins-5.76% Pretax Margin-4.51% Return on Equity-21.74% Return on Assets-8.89% Debt Debt-to-Equity Ratio0.05 Current Ratio1.51 Quick Ratio1.51 Sales & Book Value Annual Sales$4.32 billion Price / Sales0.47 Cash FlowN/A Price / Cash FlowN/A Book Value$1.63 per share Price / Book3.06Miscellaneous Outstanding Shares411,060,000Free Float397,903,000Market Cap$2.05 billion OptionableNot Optionable Beta0.52 These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesMr. Steven Jackson Sell (Age 58)President, CEO & Director Comp: $766.99kMr. Timothy S. Bensley (Age 64)Chief Financial Officer Comp: $500kMr. Girish Venkatachaliah (Age 50)Chief Technology Officer Comp: $380.19kMr. Benjamin Shaker (Age 41)Chief Markets Officer Comp: $430.19kMr. Veeral Desai (Age 43)Chief Strategy & Development Officer Comp: $404.85kMr. Timothy Gertsch (Age 37)VP, Controller & Chief Accounting Officer Mr. Matthew Dale Gillmor CFAVice President of Investor RelationsMs. Denise ZamoreChief Legal Officer & SecretaryMs. Claire MulhearnChief Communications & Public Affairs OfficerMr. Mat VargheseChief People OfficerMore ExecutivesKey CompetitorsPremierNASDAQ:PINCProgynyNASDAQ:PGNYSotera HealthNASDAQ:SHCAmphastar PharmaceuticalsNASDAQ:AMPHRecursion PharmaceuticalsNASDAQ:RXRXView All CompetitorsInsiders & InstitutionsSwiss National BankBought 3,400 shares on 5/7/2024Ownership: 0.147%Susquehanna Fundamental Investments LLCBought 487,738 shares on 5/7/2024Ownership: 0.119%Quantbot Technologies LPBought 141,280 shares on 5/6/2024Ownership: 0.034%GSA Capital Partners LLPBought 83,980 shares on 5/3/2024Ownership: 0.027%Yarger Wealth Strategies LLCSold 81,296 shares on 4/29/2024Ownership: 0.015%View All Insider TransactionsView All Institutional Transactions AGL Stock Analysis - Frequently Asked Questions Should I buy or sell agilon health stock right now? 17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for agilon health in the last year. There are currently 1 sell rating, 12 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" AGL shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AGL, but not buy additional shares or sell existing shares. View AGL analyst ratings or view top-rated stocks. What is agilon health's stock price target for 2024? 17 brokerages have issued 1 year price targets for agilon health's stock. Their AGL share price targets range from $5.00 to $18.00. On average, they anticipate the company's stock price to reach $9.32 in the next twelve months. This suggests a possible upside of 87.2% from the stock's current price. View analysts price targets for AGL or view top-rated stocks among Wall Street analysts. How have AGL shares performed in 2024? agilon health's stock was trading at $12.55 at the beginning of 2024. Since then, AGL stock has decreased by 60.3% and is now trading at $4.98. View the best growth stocks for 2024 here. How were agilon health's earnings last quarter? agilon health, inc. (NYSE:AGL) released its quarterly earnings data on Tuesday, February, 27th. The company reported ($0.41) earnings per share for the quarter, missing the consensus estimate of ($0.28) by $0.13. The business had revenue of $1.06 billion for the quarter, compared to the consensus estimate of $1.02 billion. agilon health had a negative net margin of 5.76% and a negative trailing twelve-month return on equity of 21.74%. The company's revenue for the quarter was up 71.8% on a year-over-year basis. During the same quarter last year, the business earned ($0.14) EPS. What ETFs hold agilon health's stock? ETFs with the largest weight of agilon health (NYSE:AGL) stock in their portfolio include Counterpoint Quantitative Equity ETF (CPAI), SPDR S&P Health Care Services ETF (XHS), Fidelity Disruptive Medicine ETF (FMED), Texas Capital Texas Equity Index ETF (TXS), Renaissance IPO ETF (IPO) and Fidelity Fundamental Large Cap Growth ETF (FGRO).iShares U.S. Healthcare Providers ETF (IHF). What guidance has agilon health issued on next quarter's earnings? agilon health updated its FY 2024 earnings guidance on Wednesday, May, 8th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $6.1 billion-$6.2 billion, compared to the consensus revenue estimate of $6.5 billion. When did agilon health IPO? agilon health (AGL) raised $1 billion in an IPO on Thursday, April 15th 2021. The company issued 46,600,000 shares at a price of $20.00-$23.00 per share. J.P. Morgan, Goldman Sachs, BofA Securities, Deutsche Bank Securities and Wells Fargo Securities served as the underwriters for the IPO and William Blair, Truist Securities and Nomura were co-managers. Who are agilon health's major shareholders? agilon health's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Swiss National Bank (0.15%), Susquehanna Fundamental Investments LLC (0.12%), Checchi Capital Advisers LLC (0.06%), Renaissance Capital LLC (0.05%), Quantbot Technologies LP (0.03%) and GSA Capital Partners LLP (0.03%). Insiders that own company stock include Benjamin Kornitzer, Benjamin Shaker, Cd&R Investment Associates Ix,, Glenn Sobotka, Jeffrey A Schwaneke, Joan Danieley, John William Wulf, Michael L Smith, Steven Sell, Theodore Halkias, Timothy Gertsch and Veeral Desai. View institutional ownership trends. How do I buy shares of agilon health? Shares of AGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:AGL) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsShocking: One AI startup's revenue could surge 4,735%Manward PressThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorAI “wealth window” is closing June 25thParadigm PressStock-Picking AI Predicts #1 Stock of 2024AltimetryThe #1 lithium battery stock to have on your radar in 2024!Smallcaps DailyElon Musk Secret Crypto Plot ExposedCrypto 101 MediaForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding agilon health, inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
